A Comparative Study of Predictive Models for Postoperative Pancreatic Fistula: Assessing the Original Fistula Risk Score and Duct-to-Parenchyma Ratio in a cohort of Pakistani Population
Abstract
Introduction
Clinically relevant postoperative pancreatic fistula (CR-POPF) is a major complication after pancreatoduodenectomy (PD). Predictive scores help with its early detection and management. This study assesses the effectiveness of the original Fistula Risk Score (o-FRS), duct-to-parenchyma ratio (DPR), and their combined effect in predicting CR-POPF.
Materials and Methods
This retrospective cohort study was conducted at Shaukat Khanum Memorial Cancer Hospital & Research Centre, Peshawar, from July 2021 to August 2024, including 114 patients. Approved by the Institutional Review Board (Ex-05-08-23-01), o-FRS and DPR were calculated using the Hospital Information System. Patients were categorized based on the presence or absence of CR-POPF. Risk score cut-offs used were: DPR <0.25 mm (high risk), ≥0.25 mm (low risk); duct size <3 mm (high risk), ≥3 mm (low risk); and for o-FRS: low (1–2), intermediate (3–6), and high (7–10).
Results
The study included 114 participants (59% male, 41% female) with a mean age of 50.5 ± 13 years, a mean BMI of 24.7 ± 4.5, and a median blood loss of 200 ml (IQR: 100–300 ml). CR-POPF occurred in 17.5% (20/114). Female gender (OR = 3.96, P = 0.036) and smaller duct size (OR = 0.43, P = 0.006) were significant predictors. The o-FRS showed better predictive performance (AUC = 0.709, P = 0.003) than DPR (AUC = 0.232, P = 0.006). The o-FRS had 22.1% sensitivity and 91.9% specificity, while DPR had 0% sensitivity and 76.2% specificity. Combining o-FRS and DPR was statistically significant (P = 0.001) but had low sensitivity (5%). Blood loss, age, and BMI were not significant predictors.
Conclusions
The o-FRS is more effective than the DPR in predicting CR-POPF. While the combination of o-FRS and DPR offers higher specificity, it suffers from low sensitivity and lacks external validity, thereby limiting its overall efficacy.
© 2026 Syed Irfan Kabir, Asad Ullah Khan, Mahnoor Asim, Mahnoor Durrani, Noor Ul Ain, Neelma, Fatima Gilani, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.